GSTT2 and cancer: These data align with earlier research by our group revealing that C-PAC protects patient-derived normal primary esophageal cultures against BA-induced damage through induction of glutathione S-transferase theta 2 (GSTT2), a phase II detoxification enzyme with postulated roles in esophageal mucosal defense and cancer inhibition (22, 23).